Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$728,843
+$461,999 QoQ
Shares Held
1,961
+89.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#213
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. KRYS ranks #65 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $728,843 | 1,961 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $266,844 | 1,033 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $370,055 | 1,501 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $70,257 | 398 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $248,938 | 1,811 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $293,527 | 1,628 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $104,021 | 664 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $505,496 | 2,777 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $440,918 | 2,401 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $182,199 | 1,024 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $1,405,226 | 11,327 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $840,884 | 7,249 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $184,551 | 1,572 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $103,756 | 1,296 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $242,253 | 3,058 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $29,133 | 418 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,974 | 289 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $101,938 | 1,532 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $249,581 | 3,568 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,726 | 397 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,120 | 90 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $84,589 | 1,098 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $17,820 | 297 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,185 | 74 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,561 | 86 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,334 | 54 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||